🇺🇸 FDA
Patent

US 10435695

Fusion protein comprising Gaussia luciferase, translation interrupter sequence, and interferon amino acid sequences

granted A61KA61K38/00A61K38/21

Quick answer

US patent 10435695 (Fusion protein comprising Gaussia luciferase, translation interrupter sequence, and interferon amino acid sequences) held by The Government of the United States of America, as represented by the Secretary of Homeland Security expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Government of the United States of America, as represented by the Secretary of Homeland Security
Grant date
Tue Oct 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
33
CPC classes
A61K, A61K38/00, A61K38/21